Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Validea
$12.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

NuVasive Inc Reaffirms FY 2013 Guidance


Tuesday, 30 Jul 2013 04:30pm EDT 

NuVasive Inc announced that for fiscal 2013, it expects revenue of approximately $655 million, unchanged from prior guidance. GAAP loss per share of approximately $(0.09), compared to income of $0.02 previously and Non-GAAP EPS of approximately $1.00, unchanged from prior guidance. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report EPS of $1.01 for fiscal 2013. 

Company Quote

44.6
0.62 +1.41%
27 Mar 2015